• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Improvement in anemia by recombinant human erythropoietin in patients with myelodysplastic syndrome and aplastic anemia.

作者信息

Hirashima K, Bessho M, Jinnai I

机构信息

First Department of Internal Medicine, Saitama Medical School, Japan.

出版信息

Contrib Nephrol. 1991;88:254-65. doi: 10.1159/000419534.

DOI:10.1159/000419534
PMID:2040187
Abstract
摘要

相似文献

1
Improvement in anemia by recombinant human erythropoietin in patients with myelodysplastic syndrome and aplastic anemia.
Contrib Nephrol. 1991;88:254-65. doi: 10.1159/000419534.
2
Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia.重组促红细胞生成素对骨髓增生异常综合征和再生障碍性贫血患者贫血状况的改善作用。
Int J Cell Cloning. 1990 Nov;8(6):445-58. doi: 10.1002/stem.5530080647.
3
Recombinant human erythropoietin at high dose is effective for the treatment of the anemia of myelodysplastic syndromes.
Contrib Nephrol. 1991;88:271-2; discussion 273-5.
4
Use of a functional classification of anemia in myelodysplastic syndromes to identify subgroups of patients responsive to recombinant human-erythropoietin therapy.
Eur J Haematol. 1996 Jan-Feb;56(1-2):106-8. doi: 10.1111/j.1600-0609.1996.tb00311.x.
5
In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.再生障碍性贫血和骨髓增生异常综合征患者红细胞生成的体外研究：一种前瞻性确定生长因子临床疗效的可能工具。
Hematol Pathol. 1992;6(3):143-53.
6
Recombinant human erythropoietin in patients with myelodysplastic syndrome and myelofibrosis.
Acta Haematol. 1993;90(2):65-70. doi: 10.1159/000204378.
7
Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes.皮下注射重组人促红细胞生成素治疗骨髓增生异常综合征贫血
Acta Haematol. 1993;90(2):58-64. doi: 10.1159/000204377.
8
Serum erythropoietin level and marrow erythroid infiltration predict response to recombinant human erythropoietin in myelodysplastic syndromes.血清促红细胞生成素水平和骨髓红系浸润可预测骨髓增生异常综合征患者对重组人促红细胞生成素的反应。
Haematologica. 1993 Mar-Apr;78(2):118-22.
9
Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.重组人促红细胞生成素治疗老年骨髓增生异常综合征患者的回顾性研究。
Ann Hematol. 2014 Aug;93(8):1413-20. doi: 10.1007/s00277-014-2053-9. Epub 2014 Mar 20.
10
Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes.三名骨髓增生异常综合征患者在对人重组促红细胞生成素产生过度治疗反应后，未经任何治疗贫血持续缓解。
Support Care Cancer. 2013 Jul;21(7):1803-5. doi: 10.1007/s00520-013-1818-3. Epub 2013 Apr 21.

引用本文的文献

1
The use of haemopoietic growth factors in blood disorders.造血生长因子在血液疾病中的应用。
Arch Dis Child. 1994 Dec;71(6):543-7. doi: 10.1136/adc.71.6.543.